Page last updated: 2024-11-05

tripelennamine and Syncope

tripelennamine has been researched along with Syncope in 2 studies

Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.

Syncope: A transient loss of consciousness and postural tone caused by diminished blood flow to the brain (i.e., BRAIN ISCHEMIA). Presyncope refers to the sensation of lightheadedness and loss of strength that precedes a syncopal event or accompanies an incomplete syncope. (From Adams et al., Principles of Neurology, 6th ed, pp367-9)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
KING, G1
WEEKS, SD1
Schacher, V1
Iranpour, B1
Mills, J1

Trials

1 trial available for tripelennamine and Syncope

ArticleYear
The local anesthetic efficacy of tripelennamine hydrochloride.
    Journal of oral therapeutics and pharmacology, 1967, Volume: 3, Issue:4

    Topics: Anesthesia, Dental; Anesthesia, Local; Animals; Clinical Trials as Topic; Dental Cavity Preparation;

1967

Other Studies

1 other study available for tripelennamine and Syncope

ArticleYear
PYRIBENZAMINE ACTIVATION OF THE ELECTROENCEPHALOGRAM.
    Electroencephalography and clinical neurophysiology, 1965, Volume: 18

    Topics: Adolescent; Electroencephalography; Epilepsy; Epilepsy, Absence; Epilepsy, Temporal Lobe; Epilepsy,

1965